Download PDF
Klin Monbl Augenheilkd 2017; 234(03): 370-382
DOI: 10.1055/s-0042-124533
Leitlinie
Georg Thieme Verlag KG Stuttgart · New York

Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)

DOG – Deutsche Ophthalmologische Gesellschaft
Further Information

Publication History

Publication Date:
29 March 2017 (online)

Also available at
    Permissions and Reprints

Corrected by:

Erratum: Leitlinie von DOG, RG und BVA: Retinale arterielle Verschlüsse (RAV)Klin Monbl Augenheilkd 2017; 234(03): e3-e3
DOI: 10.1055/s-0043-108139

Schlüsselwörter

Zentralarterienverschluss (ZAV) - Arterienastverschluss (AAV) - Verschluss einer zilioretinalen Arterie und Amaurosis fugax

Key words

central retinal artery occlusion (CRAO) - branch retinal artery occlusion (BRAO) - cilioretinal artery occlusion (CLRAO) - amaurosis fugax (AF)
 

  • Literatur

  • 1 Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-336
    PubMedGoogle Scholar
  • 2 Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2009; (01) CD001989
    PubMedGoogle Scholar
  • 3 Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519
    CrossrefPubMedGoogle Scholar
  • 4 Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res 2011; 30: 359-394
    CrossrefPubMedGoogle Scholar
  • 5 Duker JS, Sivalingam A, Brown GC, Reber R. A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 1991; 109: 339-342
    CrossrefPubMedGoogle Scholar
  • 6 Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011; 152: 820-823.e2
    CrossrefPubMedGoogle Scholar
  • 7 Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion.[erratum appears in Am J Ophthalmol 2000; 130: 908]. Am J Ophthalmol 1999; 128: 733-738
    CrossrefPubMedGoogle Scholar
  • 8 Rudkin AK, Lee AW, Chen CS. Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 2009; 16: 674-677
    CrossrefPubMedGoogle Scholar
  • 9 Karjalainen K. Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol (Copenh) 1971; 109: 1-96
    PubMedGoogle Scholar
  • 10 Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology 1982; 89: 14-19
    CrossrefPubMedGoogle Scholar
  • 11 Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 2014; 41: 1-25
    CrossrefPubMedGoogle Scholar
  • 12 Uhr JH, Mishra K, Wei C, Wu AY. Awareness and knowledge of emergent ophthalmic disease among patients in an internal medicine clinic. JAMA Ophthalmol 2016; 134: 424-431
    CrossrefPubMedGoogle Scholar
  • 13 Schmidt D, Schumacher M, Feltgen N. Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 2009; 247: 491-494
    CrossrefPubMedGoogle Scholar
  • 14 Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 2009; 116: 1928-1936
    CrossrefPubMedGoogle Scholar
  • 15 Hayreh SS, Zimmerman MB. Fundus changes in central retinal artery occlusion. Retina 2007; 27: 276-289
    CrossrefPubMedGoogle Scholar
  • 16 Wong TY, Klein R. Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol 2002; 13: 142-146
    CrossrefPubMedGoogle Scholar
  • 17 Naumann G. Pathologie des Auges. In: Naumann G. ed. Embryologie, Anatomie und Untersuchungstechnik. Vol. 1. 2nd ed.. Berlin: Springer; 1997: 1004-1008
    Google Scholar
  • 18 Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina 2014; 34: 115-122
    CrossrefPubMedGoogle Scholar
  • 19 Petzold A, Islam N, Hu H-H. et al. Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 2013; 58: 42-62
    CrossrefPubMedGoogle Scholar
  • 20 Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome – a systematic review. Med Sci Monit Int Med J Exp Clin Res 2012; 18: RA138-144
    PubMedGoogle Scholar
  • 21 Ness T, Bley TA, Schmidt WA. et al. The diagnosis and treatment of giant cell arteritis. Dtsch Ärztebl Int 2013; 110: 376-385 (quiz 386)
    PubMedGoogle Scholar
  • 22 Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 1988; 11: 239-251
    CrossrefPubMedGoogle Scholar
  • 23 Duker JS, Cohen MS, Brown GC. et al. Combined branch retinal artery and central retinal vein obstruction. Retina 1990; 10: 105-112
    CrossrefPubMedGoogle Scholar
  • 24 Chen S-N, Hwang J-F, Chen Y-T. Macular thickness measurements in central retinal artery occlusion by optical coherence tomography. Retina Phila Pa 2011; 31: 730-737
    PubMedGoogle Scholar
  • 25 Ritter M, Sacu S, Deák GG. et al. In vivo identification of alteration of inner neurosensory layers in branch retinal artery occlusion. Br J Ophthalmol 2012; 96: 201-207
    CrossrefPubMedGoogle Scholar
  • 26 Schmidt D, Kube T, Feltgen N. Central retinal artery occlusion: findings in optical coherence tomography and functional correlations. Eur J Med Res 2006; 11: 250-252
    PubMedGoogle Scholar
  • 27 Chu YK, Hong YT, Byeon SH. et al. In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a “prominent middle limiting membrane sign”. Retina Phila Pa 2013; 33: 2110-2117
    PubMedGoogle Scholar
  • 28 Dotan G, Goldenberg D, Kesler A. et al. The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 38-44
    CrossrefPubMedGoogle Scholar
  • 29 Brown GC, Magargal LE, Federman JL. Ischaemia and neovascularization. Trans Ophthalmol Soc U K 1980; 100: 377-380
    PubMedGoogle Scholar
  • 30 Brown GC, Magargal LE, Simeone FA. et al. Arterial obstruction and ocular neovascularization. Ophthalmology 1982; 89: 139-146
    CrossrefPubMedGoogle Scholar
  • 31 Duker JS, Brown GC. Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology 1988; 95: 1244-1250
    CrossrefPubMedGoogle Scholar
  • 32 Hayreh SS, Podhajsky PA, Zimmerman MB. Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 2009; 116: 1188-1194 e1–e4
    CrossrefPubMedGoogle Scholar
  • 33 Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005; 140: 376-391
    CrossrefPubMedGoogle Scholar
  • 34 Mukhtyar C, Guillevin L, Cid MC. et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323
    CrossrefPubMedGoogle Scholar
  • 35 Ball EL, Walsh SR, Tang TY. et al. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97: 1765-1771
    CrossrefPubMedGoogle Scholar
  • 36 Hunder GG, Bloch DA, Michel BA. et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
    PubMedGoogle Scholar
  • 37 Murchison AP, Gilbert ME, Bilyk JR. et al. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 2012; 154: 722-729
    CrossrefPubMedGoogle Scholar
  • 38 BVA und DOG. Augenärztliche Basisdiagnostik bei Patienten ab dem 7. Lebensjahr. 1998 Im Internet: http://augeninfo.de/leit/leitlinie.php?nr=leit04 Stand: 04.01.2017
    PubMedGoogle Scholar
  • 39 Watkinson S, Seewoodhary R. Administering eye medications. Nurs Stand R Coll Nurs G B 2008; 22: 42-48
    PubMedGoogle Scholar
  • 40 Wong T, Mitchell P. The eye in hypertension. Lancet 2007; 369: 425-435
    CrossrefPubMedGoogle Scholar
  • 41 Rim TH, Han J, Choi YS. et al. Retinal artery occlusion and the risk of stroke development: Twelve-year nationwide cohort study. Stroke J Cereb Circ 2016; 47: 376-382
    CrossrefPubMedGoogle Scholar
  • 42 Chang Y-S, Jan R-L, Weng S-F. et al. Retinal artery occlusion and the 3-year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 2012; 154: 645-652.e1
    CrossrefPubMedGoogle Scholar
  • 43 Amarenco P, Lavallée PC, Labreuche J. et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 2016; 374: 1533-1542
    CrossrefPubMedGoogle Scholar
  • 44 Park SJ, Choi N-K, Yang BR. et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology 2015; 122: 2336-2343
    CrossrefPubMedGoogle Scholar
  • 45 Callizo J, Feltgen N, Pantenburg S. et al. Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination. Ophthalmology 2015; 122: 1881-1888
    CrossrefPubMedGoogle Scholar
  • 46 Leisser C, Kaufmann TA, Feltgen N. et al. Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the Eagle study population. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 2015; 253: 1227-1230
    PubMedGoogle Scholar
  • 47 Rudkin AK, Lee AW, Chen CS. Vascular risk factors for central retinal artery occlusion. Eye (Lond) 2010; 24: 678-681
    CrossrefPubMedGoogle Scholar
  • 48 Hayreh SS. Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 1971; 72: 998-1011
    CrossrefPubMedGoogle Scholar
  • 49 Schmidt D, Hetzel A, Geibel-Zehender A. et al. Systemic diseases in non-inflammatory branch and central retinal artery occlusion – an overview of 416 patients. Eur J Med Res 2007; 12: 595-603
    PubMedGoogle Scholar
  • 50 Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980; 87: 75-78
    CrossrefPubMedGoogle Scholar
  • 51 Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 1995; 102: 2029-2034 discussion 2034–2035
    CrossrefPubMedGoogle Scholar
  • 52 Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 1980; 64: 913-917
    CrossrefPubMedGoogle Scholar
  • 53 Brown GC. Retinal vascular diseases. J Ophthalmic Nurs Technol 1991; 10: 71-75
    PubMedGoogle Scholar
  • 54 Mason JO, Shah AA, Vail RS. et al. Branch retinal artery occlusion: visual prognosis. Am J Ophthalmol 2008; 146: 455-457
    CrossrefPubMedGoogle Scholar
  • 55 Fraser S, Siriwardena D. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2002; (01) CD001989
    PubMedGoogle Scholar
  • 56 Varma DD, Cugati S, Lee AW. et al. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 2013; 27: 688-697
    CrossrefPubMedGoogle Scholar
  • 57 Pielen A, Junker B, Hansen L. et al. Diagnostik und Therapie beim nicht arteriitischen Zentralarterienverschluss. Klin Monatsbl Augenheilkd 2010; 227: 712-720
    Article in Thieme ConnectPubMedGoogle Scholar
  • 58 Feltgen N, Schmidt D, Hansen L. Arterielle retinale Verschlusse. Ophthalmologe 2003; 100: 651-665 quiz 666–667
    CrossrefPubMedGoogle Scholar
  • 59 Hollenhorst RW. Significance of bright plaques in the retinal arterioles. Trans Am Ophthalmol Soc 1961; 59: 252-273
    PubMedGoogle Scholar
  • 60 Hayreh SS. Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. Graefes Arch Clin Exp Ophthalmol 2007; 245: 464-466
    CrossrefPubMedGoogle Scholar
  • 61 Noble J, Weizblit N, Baerlocher MO. et al. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 2008; 92: 588-593
    CrossrefPubMedGoogle Scholar
  • 62 Fieß A, Cal O, Kehrein S. et al. Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy?. BMC Ophthalmol 2014; 14: 28
    CrossrefPubMedGoogle Scholar
  • 63 Barbón-García JJ, Alvarez-Suárez ML. [Paracentesis and ocular massage as treatment of central retinal artery occlusion]. Arch Soc Esp Oftalmol 2007; 82: 657-659
    PubMedGoogle Scholar
  • 64 Mueller A, Neubauer A, Schaller U. et al. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121: 1377-1381
    CrossrefPubMedGoogle Scholar
  • 65 Duxbury O, Bhogal P, Cloud G. et al. Successful treatment of central retinal artery thromboembolism with ocular massage and intravenous acetazolamide. BMJ Case Rep 2014; 2014 DOI: 10.1136/bcr-2014-207943.
    CrossrefPubMedGoogle Scholar
  • 66 Schmidt D. Ocular massage in a case of central retinal artery occlusion the successful treatment of a hitherto undescribed type of embolism. Eur J Med Res 2000; 5: 157-164
    PubMedGoogle Scholar
  • 67 Cope A, Eggert JV, OʼBrien E. Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen. Diving Hyperb Med 2011; 41: 135-138
    PubMedGoogle Scholar
  • 68 Menzel-Severing J, Siekmann U, Weinberger A. et al. Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 2012; 153: 454-459.e2
    CrossrefPubMedGoogle Scholar
  • 69 Aisenbrey S, Krott R, Heller R. et al. [Hyperbaric oxygen therapy in retinal artery occlusion]. Ophthalmol Z Dtsch Ophthalmol Ges 2000; 97: 461-467
    PubMedGoogle Scholar
  • 70 Weiss JN. Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2009; 36: 401-405
    PubMedGoogle Scholar
  • 71 Bertram B, Wolf S, Fisches H. et al. [Thrombolytic treatment of retinal arterial occlusions with plasminogen activator]. [German]. Klin Monatsbl Augenheilkd 1991; 198: 295-300
    Article in Thieme ConnectPubMedGoogle Scholar
  • 72 Feltgen N, Schmidt D, Schumacher M. Response to comment: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE-Group) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 2007; 245: 467-470
    CrossrefPubMedGoogle Scholar
  • 73 Deutsche Schlaganfall Gesellschaft. Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke. AWMF-Register 2015; Nr. 030 – 133.
    PubMedGoogle Scholar
  • 74 Feltgen N, Neubauer A, Jurklies B. et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244: 950-956
    CrossrefPubMedGoogle Scholar
  • 75 Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 2000; 84: 914-916
    CrossrefPubMedGoogle Scholar
  • 76 Hazin R, Dixon JA, Bhatti MT. Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy?. Curr Opin Ophthalmol 2009; 20: 210-218
    CrossrefPubMedGoogle Scholar
  • 77 Vallee JN, Aymard A, Paques M. et al. [Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion]. J Radiol 2001; 82: 137-144
    PubMedGoogle Scholar
  • 78 Von Mach M-A, Güz A, Wiechelt J. et al. [Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study] 1946. Dtsch Med Wochenschr 2005; 130: 1002-1006
    Article in Thieme ConnectPubMedGoogle Scholar
  • 79 Schumacher M, Schmidt D, Jurklies B. et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 2010; 117: 1367-1375.e1
    CrossrefPubMedGoogle Scholar
  • 80 Chen CS, Lee AW, Campbell B. et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke J Cereb Circ 2011; 42: 2229-2234
    CrossrefPubMedGoogle Scholar
  • 81 Hattenbach L-O, Kuhli-Hattenbach C, Scharrer I. et al. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 2008; 146: 700-706
    CrossrefPubMedGoogle Scholar
  • 82 Schrag M, Youn T, Schindler J. et al. Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 2015; 72: 1148-1154
    CrossrefPubMedGoogle Scholar
  • 83 Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. Ajnr Am J Neuroradiol 2002; 23: 1301-1307
    PubMedGoogle Scholar
  • 84 Kiesewetter H, Blume J, Jung F. et al. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage II b. J Intern Med 1990; 227: 107-114
    CrossrefPubMedGoogle Scholar
  • 85 Roth S. The effects of isovolumic hemodilution on ocular blood flow. Exp Eye Res 1992; 55: 59-63
    PubMedGoogle Scholar
  • 86 Neely KA, Ernest JT, Goldstick TK. et al. Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol 1996; 234: 688-694
    CrossrefPubMedGoogle Scholar
  • 87 Rüfer F, Schröder A, Winter R. et al. [Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion]. Ophthalmol Z Dtsch Ophthalmol Ges 2003; 100: 819-824
    PubMedGoogle Scholar
  • 88 Wiederholt M, Leonhardt H, Schmid-Schönbein H. et al. [Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution (authorʼs transl)]. Klin Monatsbl Augenheilkd 1980; 177: 157-164
    Article in Thieme ConnectPubMedGoogle Scholar
  • 89 Wolf S, Hoberg A, Bertram B. et al. [Video fluorescein angiography follow-up of patients with retinal artery occlusion]. [German]. Klin Monatsbl Augenheilkd 1989; 195: 154-160
    Article in Thieme ConnectPubMedGoogle Scholar
  • 90 Arend O, Hoberg A, Bertram B. et al. [Hemodilution in acute arterial circulatory disorders of the retina]. [German]. Acta Med Austriaca 1991; 18: 66-68
    PubMedGoogle Scholar
  • 91 Diener H-C, Aisenberg J, Ansell J. et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. Eur Heart J DOI: 10.1093/eurheartj/ehv643. online publication 04.02.2016;
    CrossrefPubMedGoogle Scholar
  • 92 Diener H-C, Aisenberg J, Ansell J. et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. Eur Heart J DOI: 10.1093/eurheartj/ehw069. online publication 04.02.2016;
    CrossrefPubMedGoogle Scholar
  • 93 Diener H-C, Kleinschnitz C. Non-vitamin K oral anticoagulants in stroke patients: practical issues. J Stroke 2016; 18: 138-145
    CrossrefPubMedGoogle Scholar
  • 94 Sandercock P, Gubitz G, Foley P. et al. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003; (02) CD000029
    PubMedGoogle Scholar
  • 95 Rothwell PM, Algra A, Chen Z. et al. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 2016; 388: 365-375
    CrossrefPubMedGoogle Scholar
  • 96 Frayser R, Saltzman HA, Anderson B. et al. The effect of hyperbaric oxygenation on retinal circulation. Arch Ophthalmol 1967; 77: 265-269
    CrossrefPubMedGoogle Scholar
  • 97 Nichols CW, Lambertsen C. Effects of high oxygen pressures on the eye. N Engl J Med 1969; 281: 25-30
    CrossrefPubMedGoogle Scholar
  • 98 Oguz H, Sobaci G. The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 2008; 53: 112-120
    CrossrefPubMedGoogle Scholar
  • 99 Butler FK, Hagan C, Murphy-Lavoie H. Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2008; 35: 333-387
    PubMedGoogle Scholar
  • 100 Murphy-Lavoie H, Butler F, Hagan C. Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc 2012; 39: 943-953
    PubMedGoogle Scholar
  • 101 Jampol LM. Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc 1987; 85: 407-437
    PubMedGoogle Scholar
  • 102 Gaydar V, Ezrachi D, Dratviman-Storobinsky O. et al. Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment. Invest Ophthalmol Vis Sci 2011; 52: 7514-7522
    CrossrefPubMedGoogle Scholar
  • 103 Christiansen CB, Lip GYH, Lamberts M. et al. Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost JTH 2013; 11: 1485-1492
    CrossrefPubMedGoogle Scholar
  • 104 Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003; 136: 1136-1150
    CrossrefPubMedGoogle Scholar
  • 105 Bertram B, Remky A, Arend O. et al. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995; 4: 332-335
    PubMedGoogle Scholar
  • 106 Marcucci R, Sodi A, Giambene B. et al. Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion. Blood Coagul Fibrinolysis Int J Haemost Thromb 2007; 18: 321-326
    PubMedGoogle Scholar
  • 107 BVA und DOG. Anteriore ischämische Opticus-Neuropathie (AION), Leitlinie Nr 29. 2001. http://augeninfo.de/leit/leitlinie.php?nr=leit29 Stand: 04.01.2017
    PubMedGoogle Scholar
  • 108 Duker JS, Brown GC. Neovascularization of the optic disc associated with obstruction of the central retinal artery. Ophthalmology 1989; 96: 87-91
    CrossrefPubMedGoogle Scholar
  • 109 Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 1991; 15: 15-20
    CrossrefPubMedGoogle Scholar
  • 110 Sivalingam A, Brown GC, Magargal LE. et al. The ocular ischemic syndrome. II. Mortality and systemic morbidity. Int Ophthalmol 1989; 13: 187-191
    CrossrefPubMedGoogle Scholar